A Clinical Trial to Evaluate the Effects of a Supplement on Children's Focus and Energy

Auri Nutrition

Status

Active, not recruiting

Conditions

Poor Concentration

Low Energy

Poor Memory

Difficulty Focusing

Treatments

Dietary Supplement: Auri Super Mushroom Daily Gummies For Kids

Study type

Interventional

Funder types

Industry

Identifiers

NCT07766642

legacy-20827

20827

Details and patient eligibility

About

This study will evaluate the effects of the Auri Super Mushroom Daily Gummies For Kids on focus and energy in children aged 4-12. The study is a single-arm, unblinded, virtual trial conducted over 8 weeks, in which all 35 enrolled participants will use the test product daily.

Parents of the participants will complete questionnaires at Baseline, Week 2, Week 4, Week 6, and Week 8 to assess perceived changes in their child's focus, attention, sleep quality, gut health, natural energy, and overall well-being. Participants will also undergo cognitive battery testing at Baseline, Week 4, and Week 8 to provide objective measurements of focus and cognitive performance.

Enrollment

35 patients

Sex

All

Ages

4 to 12 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Be male or female.
Be aged 4-12.
Parent(s) reporting that their child has been experiencing issues regarding any of the following for the past four weeks: Difficulty focusing, Poor concentration, or Poor memory.
Parent(s) who report that their child will be willing to complete cognitive assessments at regular intervals during the study.
Any child who is generally healthy - does not live with any uncontrolled chronic disease.
Parent(s) who are willing to follow the study protocol and support their child to complete all study actions.
Any child who has no planned changes to school schedule, sleep routines, or behavioral therapies during the study duration.
Anyone willing to refrain from introducing any new prescription medications, wellness products, supplements, or herbal remedies into their child's routine during the test period.
If the child has been taking any other products, supplements, or herbal remedies, they have been taking these consistently for at least three months.
Has had a stable diet and sleep schedule for at least four weeks prior to the study.
Enrolled in and currently attending school at baseline and for the duration of the study period.
Resides in the United States.

Exclusion criteria

Any child with a neurodevelopmental condition or developmental delay, including autism spectrum disorder, intellectual disability, language disorder, uncontrolled anxiety or mood disorder, or dyslexia.
Previous diagnosis of Attention-deficit hyperactivity disorder (ADHD).
Any child currently undergoing any assessments for suspected neurodevelopmental conditions or developmental delay.
Any child diagnosed with epilepsy or a seizure disorder.
Any child diagnosed with a bleeding disorder.
Any child with any known allergies or hypersensitivities to any supplement product ingredients.
Any child with any chronic health conditions that could impact their participation in this study, such as cancer, mental health disorders, a history of serious illness in the last three months, or planned surgery during the study period.
Any parent or child currently testing, or planning on starting in the next eight weeks, a product for another research study.